NRP1hi cells derived from 7 different tumors of patients with GBM revealed significantly enriched scores for stemness and TGF-β signaling compared with matched NRP1lo/– cells (Figure 7, A–C). This evidence concerns the gene TGFB1 and glioblastoma.